MedTrace Logo

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

NCT06640465 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-03-04

No results posted yet for this study

Summary

The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations.

An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commercially available dietary supplements on increasing CoQ10 concentrations and self-reported health outcomes.

Conditions

  • Wellness
  • Health

Interventions

DIETARY_SUPPLEMENT

Ubiquinol + geranylgeraniol

Combination of ubiquinol and geranylgeraniol

DIETARY_SUPPLEMENT

Geranylgeraniol

Geranylgeraniol alone

DIETARY_SUPPLEMENT

Ubiquinol

Ubiquinol alone

DIETARY_SUPPLEMENT

Ubiquinone

Ubiquinone alone

OTHER

Placebo

Placebo capsule

Sponsors & Collaborators

  • OvationLab

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-12
Primary Completion
2025-09-17
Completion
2025-09-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640465 on ClinicalTrials.gov